Valeant names former finance chief Howard Schiller as interim CEO as current CEO remains ill

NEW YORK, N.Y. – Valeant Pharmaceuticals named former finance chief Howard Schiller as interim CEO of the troubled pharmaceutical company, while current CEO J. Michael Pearson recovers from severe pneumonia.

The company said Wednesday that it does not know when Pearson will return to the company. Shares of Valeant Pharmaceuticals International Inc. fell about 3 per cent in premarket trading.

Schiller was chief financial officer of Valeant up until June. He’s currently on the Canadian company’s board.

Valeant has recently come under scrutiny for its drug pricing policies, as well as its relationship with the mail-order pharmacy Philidor.

News from © The Associated Press, . All rights reserved.
This material may not be published, broadcast, rewritten or redistributed.

The Associated Press

The Associated Press is an independent global news organization dedicated to factual reporting. Founded in 1846, AP today remains the most trusted source of fast, accurate, unbiased news in all formats and the essential provider of the technology and services vital to the news business. More than half the world’s population sees AP journalism every day.